Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Opioid-Induced Constipation × Dosage Forms × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 3 Leukemia 3 Vomiting 2 Stomach Neoplasms 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Urologic Neoplasms 1 Urogenital Neoplasms 1 Substance-Related Disorders 1 Solid Tumors 1 Pituitary Neoplasms 1 Pancreatic Neoplasms 1 Opioid-Related Disorders 1 Opioid-Induced Constipation 1 Neurofibromatosis 1 1 Neoplasms 1 Myelodysplastic Syndromes 1 Motor Activity 1 Lymphoma, Follicular 1 Lymphoma 1 Low Anterior Resection Syndrome 1 Kidney Neoplasms 1 Hematologic Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Cancer Pain 1 Breast Neoplasms 1 Agnosia 1 Advanced Solid Tumors 1 Acromegaly 1

Interventions

naloxegol 6 tegaserod 3 naldemedine 3 prucalopride 1 methylnaltrexone 1 linaclotide 1 alvimopan 1 Polyethylene Glycols 1 Oxycodone 1 Magnesium Hydroxide 1 Lubiprostone 1 Electrolytes 1 Electroacupuncture 1 Dosage Forms 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05216328 2024-11-22

OMAMA

Amsterdam UMC, location VUmc

Phase 4 Recruiting

Cancer Pain, Opioid-Induced Constipation, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡